The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Aims/Purpose: Corneal collagen cross‐linking (CXL) treatment is widely applied to halt the progression of ectatic diseases such as keratoconus. Unfortunately, the standard CXL procedure based on riboflavin and UV‐A light can only be applied to cornea thicker than 400 μm and results in frequent complications, such as corneal haze and endothelial damage [1]. This study investigates a new CXL procedure...
Purpose
Keratoconus is a progressive disease which results thinning of the cornea and increase in the forward curvature of the cornea until corneal rupture. The first choice in clinical management of keratoconus is Ultraviolet‐A(UV‐A) crosslinking procedure with riboflavin. This procedure is painful, prolonged and has many side effects on the patient. Eosin‐y is well known molecule and it has been...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.